Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed three additional patent infringement suits relating to BGI?s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents. The first complaint was filed against Complete Genomics, Inc. and other BGI entities in the United States District Court for the Northern District of California alleging infringement of U.S. Patent Nos. 7,566,537 and 9,410,200. The second complaint was f